Wolff Wiese Magana LLC Has $254,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Wolff Wiese Magana LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 435 shares of the healthcare conglomerate’s stock after purchasing an additional 61 shares during the quarter. Wolff Wiese Magana LLC’s holdings in UnitedHealth Group were worth $254,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Amplius Wealth Advisors LLC lifted its position in UnitedHealth Group by 3.3% in the 3rd quarter. Amplius Wealth Advisors LLC now owns 978 shares of the healthcare conglomerate’s stock valued at $572,000 after acquiring an additional 31 shares in the last quarter. Leisure Capital Management grew its holdings in UnitedHealth Group by 4.3% during the third quarter. Leisure Capital Management now owns 2,932 shares of the healthcare conglomerate’s stock worth $1,714,000 after buying an additional 121 shares in the last quarter. McKinley Carter Wealth Services Inc. lifted its stake in UnitedHealth Group by 2.6% during the 3rd quarter. McKinley Carter Wealth Services Inc. now owns 19,286 shares of the healthcare conglomerate’s stock valued at $11,276,000 after acquiring an additional 490 shares in the last quarter. Sumitomo Life Insurance Co. grew its stake in shares of UnitedHealth Group by 19.7% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 25,220 shares of the healthcare conglomerate’s stock worth $14,746,000 after acquiring an additional 4,157 shares in the last quarter. Finally, Verum Partners LLC boosted its holdings in UnitedHealth Group by 2.9% during the third quarter. Verum Partners LLC now owns 1,575 shares of the healthcare conglomerate’s stock worth $921,000 after purchasing an additional 44 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $571.30 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $527.55 billion, a P/E ratio of 37.88, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The firm has a 50 day moving average of $584.21 and a 200-day moving average of $532.84.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. KeyCorp started coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $615.16.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.